Stryker PE Ratio 2010-2023 | SYK
Current and historical p/e ratio for Stryker (SYK) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Stryker PE ratio as of April 17, 2024 is 31.70.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Stryker PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-17 | 336.03 | 40.73 | |
| 2023-12-31 | 298.79 | $8.25 | 36.22 |
| 2023-09-30 | 271.93 | $6.74 | 40.35 |
| 2023-06-30 | 302.77 | $7.08 | 42.76 |
| 2023-03-31 | 282.60 | $6.87 | 41.13 |
| 2022-12-31 | 241.38 | $6.17 | 39.12 |
| 2022-09-30 | 199.36 | $6.43 | 31.00 |
| 2022-06-30 | 195.14 | $5.43 | 35.94 |
| 2022-03-31 | 261.35 | $5.26 | 49.69 |
| 2021-12-31 | 260.75 | $5.21 | 50.05 |
| 2021-09-30 | 256.48 | $4.97 | 51.61 |
| 2021-06-30 | 252.01 | $5.46 | 46.16 |
| 2021-03-31 | 235.77 | $3.69 | 63.89 |
| 2020-12-31 | 236.57 | $4.20 | 56.33 |
| 2020-09-30 | 200.64 | $4.61 | 43.52 |
| 2020-06-30 | 173.02 | $4.21 | 41.10 |
| 2020-03-31 | 159.35 | $5.69 | 28.01 |
| 2019-12-31 | 200.23 | $5.48 | 36.54 |
| 2019-09-30 | 205.73 | $9.02 | 22.81 |
| 2019-06-30 | 195.06 | $9.34 | 20.88 |
| 2019-03-31 | 186.93 | $9.27 | 20.17 |
| 2018-12-31 | 147.95 | $9.34 | 15.84 |
| 2018-09-30 | 167.15 | $3.24 | 51.59 |
| 2018-06-30 | 158.43 | $2.83 | 55.98 |
| 2018-03-31 | 150.56 | $2.67 | 56.39 |
| 2017-12-31 | 144.44 | $2.85 | 50.68 |
| 2017-09-30 | 132.08 | $4.45 | 29.68 |
| 2017-06-30 | 128.68 | $4.31 | 29.86 |
| 2016-12-31 | 110.40 | $4.35 | 25.38 |
| 2016-09-30 | 106.89 | $4.39 | 24.35 |
| 2016-06-30 | 109.67 | $4.62 | 23.74 |
| 2016-03-31 | 97.87 | $4.41 | 22.19 |
| 2015-12-31 | 84.48 | $4.37 | 19.33 |
| 2017-03-31 | 121.70 | $3.57 | 34.09 |
| 2015-09-30 | 85.19 | $3.07 | 27.75 |
| 2015-06-30 | 86.20 | $2.44 | 35.33 |
| 2015-03-31 | 82.92 | $1.97 | 42.09 |
| 2014-12-31 | 84.47 | $1.57 | 53.80 |
| 2014-09-30 | 72.05 | $1.91 | 37.72 |
| 2014-06-30 | 74.95 | $2.02 | 37.11 |
| 2014-03-31 | 72.16 | $2.02 | 35.72 |
| 2013-12-31 | 66.30 | $2.63 | 25.21 |
| 2013-09-30 | 59.40 | $2.33 | 25.49 |
| 2013-06-30 | 56.62 | $2.98 | 19.00 |
| 2013-03-31 | 56.88 | $3.27 | 17.39 |
| 2012-12-31 | 47.60 | $3.39 | 14.04 |
| 2012-09-30 | 48.10 | $3.73 | 12.89 |
| 2012-06-30 | 47.43 | $3.65 | 13.00 |
| 2012-03-31 | 47.57 | $3.59 | 13.25 |
| 2011-12-31 | 42.46 | $3.46 | 12.27 |
| 2011-09-30 | 40.09 | $3.15 | 12.73 |
| 2011-06-30 | 49.73 | $3.16 | 15.74 |
| 2011-03-31 | 51.37 | $3.17 | 16.20 |
| 2010-12-31 | 45.23 | $3.19 | 14.18 |
| 2010-09-30 | 42.02 | $3.21 | 13.09 |
| 2010-06-30 | 41.90 | $2.93 | 14.30 |
| 2010-03-31 | 47.76 | $2.86 | 16.70 |
| 2009-12-31 | 41.93 | $2.77 | 15.14 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $127.849B | $20.498B |
| Stryker Corporation is a medical device company operating in the global orthopedic market. The company has three business segments: Orthopaedics, MedSurg and Neurotechnology & Spine. Orthopaedic?products include implants used in hip and knee joint replacements and trauma and extremities surgeries. MedSurg?products consists of surgical equipment and surgical navigation systems; endoscopic and communications systems; patient handling and emergency medical equipment and reprocessed and remanufactured medical devices. Neurotechnology & Spine division includes both neurosurgical and neurovascular devices. These includes products used for minimally invasive endovascular techniques; traditional brain and open skull base surgical procedures; orthobiologic and biosurgery products and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. Spinal implant product offering includes cervical, thoracolumbar and interbody systems used in spinal injury, deformity and degenerative therapies. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $183.756B | 24.12 |
| Medtronic (MDT) | Ireland | $105.004B | 14.86 |
| Boston Scientific (BSX) | United States | $99.704B | 33.15 |
| EssilorLuxottica (ESLOY) | France | $97.123B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $42.671B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.031B | 28.96 |
| ResMed (RMD) | United States | $25.568B | 25.56 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.922B | 16.05 |
| Terumo (TRUMY) | Japan | $24.880B | 35.14 |
| Baxter (BAX) | United States | $20.069B | 14.64 |
| Koninklijke Philips (PHG) | Netherlands | $18.712B | 14.93 |
| Insulet (PODD) | United States | $11.642B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.457B | 0.00 |
| Demant (WILYY) | Denmark | $10.001B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.295B | 24.71 |
| BellRing Brands (BRBR) | United States | $7.115B | 38.25 |
| Haemonetics (HAE) | United States | $4.311B | 22.05 |
| Lantheus Holdings (LNTH) | United States | $4.215B | 10.88 |
| Perrigo (PRGO) | Ireland | $4.071B | 11.64 |
| GN Store Nord (GNNDY) | Denmark | $3.675B | 23.80 |
| Prestige Consumer Healthcare (PBH) | United States | $3.378B | 15.97 |
| Envista Holdings (NVST) | United States | $3.367B | 12.80 |
| Green Thumb Industries (GTBIF) | United States | $2.758B | 87.40 |
| Neogen (NEOG) | United States | $2.630B | 25.29 |
| QuidelOrtho (QDEL) | United States | $2.589B | 9.40 |
| ICU Medical (ICUI) | United States | $2.336B | 17.43 |
| TG Therapeutics (TGTX) | United States | $2.134B | 691.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.943B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.858B | 0.00 |
| Owens & Minor (OMI) | United States | $1.836B | 17.62 |
| Agios Pharmaceuticals (AGIO) | United States | $1.631B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.486B | 46.29 |
| InMode (INMD) | Israel | $1.465B | 7.59 |
| LeMaitre Vascular (LMAT) | United States | $1.415B | 46.70 |
| AdaptHealth (AHCO) | United States | $1.253B | 9.43 |
| Warby Parker (WRBY) | United States | $1.189B | 0.00 |
| AtriCure (ATRC) | United States | $1.134B | 0.00 |
| MacroGenics (MGNX) | United States | $1.007B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.757B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.687B | 14.83 |
| BioLife Solutions (BLFS) | United States | $0.686B | 0.00 |
| Evolus (EOLS) | United States | $0.674B | 0.00 |
| Jin Medical (ZJYL) | China | $0.631B | 0.00 |
| Quanterix (QTRX) | United States | $0.602B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.591B | 0.00 |
| Valneva SE (VALN) | France | $0.538B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.533B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.521B | 11.29 |
| PetIQ (PETQ) | United States | $0.469B | 17.50 |
| ZimVie (ZIMV) | United States | $0.417B | 25.55 |
| Biote (BTMD) | United States | $0.411B | 3.91 |
| OraSure Technologies (OSUR) | United States | $0.402B | 6.65 |
| Zynex (ZYXI) | United States | $0.388B | 44.70 |
| Surmodics (SRDX) | United States | $0.378B | 40.80 |
| Aurora Cannabis (ACB) | Canada | $0.316B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.303B | 30.08 |
| Cerus (CERS) | United States | $0.297B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.272B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.256B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.243B | 14.80 |
| Ayr Wellness (AYRWF) | United States | $0.210B | 0.00 |
| Omeros (OMER) | United States | $0.194B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.189B | 0.00 |
| High Tide (HITI) | Canada | $0.178B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.175B | 0.00 |
| Veru (VERU) | United States | $0.170B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.154B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.138B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.136B | 21.93 |
| Eagleford Energy (GRUSF) | United States | $0.135B | 68.05 |
| InterCure (INCR) | Israel | $0.108B | 18.15 |
| Fonar (FONR) | United States | $0.105B | 8.98 |
| Allurion Technologies (ALUR) | United States | $0.104B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.104B | 0.00 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Safety Shot (SHOT) | United States | $0.097B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.094B | 0.00 |
| Brainsway (BWAY) | Israel | $0.084B | 0.00 |
| Chimerix (CMRX) | United States | $0.081B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.073B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.057B | 3.72 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.041B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.036B | 14.04 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.021B | 0.00 |
| Flora Growth (FLGC) | United States | $0.019B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.019B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Agape ATP (ATPC) | $0.018B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 73.36 |
| ProSomnus (OSA) | United States | $0.008B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.007B | 0.00 |
| Sharps Technology (STSS) | United States | $0.005B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |